441
Views
16
CrossRef citations to date
0
Altmetric
Reviews

Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond

, &
Pages 615-628 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Vo Van Giau, Hyon Lee, Seong Soo A An & John Hulme. (2019) Recent advances in the treatment of C. difficile using biotherapeutic agents. Infection and Drug Resistance 12, pages 1597-1615.
Read now
Kathryn A Bowman, Elizabeth K Broussard & Christina M Surawicz. (2015) Fecal microbiota transplantation: current clinical efficacy and future prospects. Clinical and Experimental Gastroenterology 8, pages 285-291.
Read now
Dana Berg, Jose C Clemente & Jean-Frederic Colombel. (2015) Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?. Expert Review of Gastroenterology & Hepatology 9:6, pages 781-795.
Read now

Articles from other publishers (13)

Qianru Zhao, Yuwei Wang, Zhengming Zhu, Quanyu Zhao, Liying Zhu & Ling Jiang. (2023) Efficient reduction of β-lactoglobulin allergenicity in milk using Clostridium tyrobutyricum Z816. Food Science and Human Wellness 12:3, pages 809-816.
Crossref
Rei Kawashima, Shun Tamaki, Fumitaka Kawakami, Tatsunori Maekawa & Takafumi Ichikawa. (2020) Histamine H2-Receptor Antagonists Improve Non-Steroidal Anti-Inflammatory Drug-Induced Intestinal Dysbiosis. International Journal of Molecular Sciences 21:21, pages 8166.
Crossref
Lynne V. McFarland, Christina M. Surawicz & Stephen M. Vindigni. 2019. Evidence‐based Gastroenterology and Hepatology 4e. Evidence‐based Gastroenterology and Hepatology 4e 284 305 .
Sajiv Chandradas, Hamed Khalili, Ashwin Ananthakrishnan, Connor Wayman, Warren Reidel, Jill Waalen & Gauree G. Konijeti. (2018) Does Obesity Influence the Risk of Clostridium difficile Infection Among Patients with Ulcerative Colitis?. Digestive Diseases and Sciences 63:9, pages 2445-2450.
Crossref
Ulrich Desselberger. (2018) The Mammalian Intestinal Microbiome: Composition, Interaction with the Immune System, Significance for Vaccine Efficacy, and Potential for Disease Therapy. Pathogens 7:3, pages 57.
Crossref
Stephen M. Vindigni & Christina M. Surawicz. (2017) Fecal Microbiota Transplantation. Gastroenterology Clinics of North America 46:1, pages 171-185.
Crossref
E. L. Nikonov & V. A. Aksenov. (2017) Transplantation of fecal microbiota or probiotics?. Dokazatel'naya gastroenterologiya 6:3, pages 19.
Crossref
Dai Ishikawa, Takashi Sasaki, Taro Osada, Kyoko Kuwahara-Arai, Keiichi Haga, Tomoyoshi Shibuya, Keiichi Hiramatsu & Sumio Watanabe. (2017) Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis. Inflammatory Bowel Diseases 23:1, pages 116-125.
Crossref
Diane J. Schmidt, Gillian Beamer, Jacqueline M. Tremblay, Jennifer A. Steele, Hyeun Bum Kim, Yaunkai Wang, Michele Debatis, Xingmin Sun, Elena A. Kashentseva, Igor P. Dmitriev, David T. Curiel, Charles B. Shoemaker & Saul Tzipori. (2016) A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection. Clinical and Vaccine Immunology 23:9, pages 774-784.
Crossref
Stephen M Vindigni & Christina M Surawicz. (2015) C. difficile Infection: Changing Epidemiology and Management Paradigms. Clinical and Translational Gastroenterology 6:7, pages e99.
Crossref
Cade M. Nylund, Matilda Eide & Gregory H. Gorman. (2014) Association of Clostridium difficile Infections with Acid Suppression Medications in Children. The Journal of Pediatrics 165:5, pages 979-984.e1.
Crossref
Mak Adam Daulatzai. 2014. Behavioral Neurobiology of Stress-related Disorders. Behavioral Neurobiology of Stress-related Disorders 265 296 .
E Susan Amirian, Joseph F Petrosino, Nadim J Ajami, Yanhong Liu, Martha P Mims & Michael E Scheurer. (2013) Potential role of gastrointestinal microbiota composition in prostate cancer risk. Infectious Agents and Cancer 8:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.